GAUGLER DARYL 4
4 · Pacira BioSciences, Inc. · Filed Jun 2, 2023
Insider Transaction Report
Form 4
GAUGLER DARYL
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2023-05-31$34.00/sh+2,500$85,000→ 26,894 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-05-31−2,500→ 0 totalExercise: $34.00Exp: 2023-06-04→ Common Stock (2,500 underlying) - Sale
Common Stock
2023-05-31$39.08/sh−2,500$97,700→ 24,591 total
Footnotes (3)
- [F1]The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]Includes an aggregate of 197 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022 and December 2022.
- [F3]The stock option vested in equal monthly installments over one year following the grant date, provided that the reporting person remained in continuous service with the issuer as of each vesting date.